Braveheart Investment Group PLC
LSE:BRH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Braveheart Investment Group PLC
Cash Paid for Dividends
Braveheart Investment Group PLC
Cash Paid for Dividends Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Paid for Dividends | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Braveheart Investment Group PLC
LSE:BRH
|
Cash Paid for Dividends
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Janus Henderson Group PLC
NYSE:JHG
|
Cash Paid for Dividends
-$249.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
3i Group PLC
LSE:III
|
Cash Paid for Dividends
-£701m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-14%
|
|
|
Schroders PLC
LSE:SDR
|
Cash Paid for Dividends
-£337.6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
N
|
Ninety One PLC
LSE:N91
|
Cash Paid for Dividends
-£109.7m
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
A
|
Allfunds Group PLC
AEX:ALLFG
|
Cash Paid for Dividends
-€80m
|
CAGR 3-Years
28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Braveheart Investment Group PLC
Glance View
Braveheart Investment Group Plc engages in the provision of debt or equity and advisory services. The company is headquartered in Barnsley, South Yorkshire. The company went IPO on 2007-03-30. The firm holds investments in over five companies, including Phasefocus Holdings Limited, Paraytec Limited, Sentinel Medical Limited, Kirkstall Limited and Gyrometric Systems Limited. Its subsidiaries include Caledonia Portfolio Realisations Limited, Braveheart Academic Seed Funding GP Limited, Ridings Holdings Limited and The Ridings Early Growth Investment Company Limited. Its subsidiary, Kirkstall Limited, operates in the organ-on-a-chip market, where it has developed Quasi Vivo, a system of chambers for cell and tissue culture in laboratories. Its subsidiary, Paraytec Limited, develops high performance specialist detectors for the analytical and life sciences instrumentation market.